Skip to main content
. 2012 Aug;8(3):177–180. doi: 10.2174/157340312803217157

Fig. (1).

Fig. (1)

Ninety-day incidences of death, congestive heart failure (CHF) or stroke (primary endpoint), reinfarction, target vessel revascularization (TVR) and stroke in the Facilitated PCI (black) and Primary PCI (white) groups from the ASSENT 4 study. The trial was prematurely interrupted because of the observed increased risk of adverse events in the Facilitated PCI arm. PCI = percutaneous coronary intervention.